Cite
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.
MLA
Tan, Eng Hooi, et al. “COVID-19 in Patients with Autoimmune Diseases: Characteristics and Outcomes in a Multinational Network of Cohorts across Three Countries.” Rheumatology, vol. 60, Oct. 2021, pp. SI37-SI50. EBSCOhost, https://doi.org/10.1093/rheumatology/keab250.
APA
Tan, E. H., Sena, A. G., Prats-Uribe, A., You, S. C., Ahmed, W.-U.-R., Kostka, K., Reich, C., Duvall, S. L., Lynch, K. E., Matheny, M. E., Duarte-Salles, T., Bertolin, S. F., Hripcsak, G., Natarajan, K., Falconer, T., Spotnitz, M., Ostropolets, A., Blacketer, C., Alshammari, T. M., & Alghoul, H. (2021). COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology, 60, SI37-SI50. https://doi.org/10.1093/rheumatology/keab250
Chicago
Tan, Eng Hooi, Anthony G Sena, Albert Prats-Uribe, Seng Chan You, Waheed-Ul-Rahman Ahmed, Kristin Kostka, Christian Reich, et al. 2021. “COVID-19 in Patients with Autoimmune Diseases: Characteristics and Outcomes in a Multinational Network of Cohorts across Three Countries.” Rheumatology 60 (October): SI37-SI50. doi:10.1093/rheumatology/keab250.